Abbott was founded in 1991 and is headquartered in Illinois City, US

CEO

CFO

Executive Vice President, Human Resources

Abbott has offices in Illinois City, Sao Paulo, Shanghai, Beijing and in 5 other locations

Illinois City, US (HQ)

Abbott Park

Québec, CA

8401 Trans Canada Highway, Saint Laurent

Maidenhead, GB

Abbott House, Vanwall Business Park, Vanwall Road

Wiesbaden, DE

Abbott Gmb H & Co. Kg, Max Planck Ring 2

Seoul, KR

Samtan Bldg., 3rd Floor, 421 Young Dong Daero, Kangnam Ku

Tokyo, JP

3 5 27, Mita, Minato Ku

Beijing, CN

17 F, Canway Builing, No. 66 Nanlishi Road

Shanghai, CN

23 F/26 F/27 F/28 F/32 F/33 F/36 F/37 F/39 F, Ciro’s Plaza, No. 388 West Nanjing Road

Sao Paulo, BR

Rua Michigan, 735 – Brooklin

## Revenue (2016) | $20.9 b |

## Revenue growth (2015-16), % | 2% |

## Gross profit | $11.8 b |

## Gross profit margin (2016), % | 57% |

## Net income (2016) | $1.4 b |

## Market capitalization (28-Apr-2017) | $75.4 b |

## Closing share price (28-Apr-2017) | $43.7 |

## Cash (31-Dec-2016) | $18.6 b |

Abbott's current market capitalization is $75.4 b.

- Source: SEC Filings

Abbott's revenue was reported to be $20.9 b in FY, 2016 which is a **2% increase** from the previous period.

FY, 2013^{} | FY, 2014^{} | FY, 2015^{} | FY, 2016^{} | |
---|---|---|---|---|

## Revenue | $21.8 b | $20.2 b | $20.4 b | $20.9 b |

## Revenue growth, % | (7%) | 1% | 2% | |

## Cost of goods sold | $10 b | $9.2 b | $8.7 b | $9 b |

## Gross profit | $11.8 b | $11 b | $11.7 b | $11.8 b |

## Gross profit Margin, % | 54% | 54% | 57% | 57% |

## Operating expense total | $9.2 b | $17.6 b | $17.5 b | $17.7 b |

## EBIT | $2.6 b | $2.6 b | $2.9 b | $3.2 b |

## EBIT margin, % | 12% | 13% | 14% | 15% |

## Interest expense | $157 m | $150 m | $163 m | $431 m |

## Interest income | $67 m | $77 m | $105 m | $99 m |

## Income tax expense | $53 m | $797 m | $577 m | $350 m |

## Net Income | $2.6 b | $2.3 b | $4.4 b | $1.4 b |

- Source: SEC Filings

FY, 2013^{} | FY, 2014^{} | FY, 2015^{} | FY, 2016^{} | |
---|---|---|---|---|

## Cash | $3.5 b | $4.1 b | $5 b | $18.6 b |

## Accounts Receivable | $4 b | $3.6 b | $3.4 b | $3.2 b |

## Inventories | $2.7 b | $2.6 b | $2.6 b | $2.4 b |

## Current Assets | $19.2 b | $15.3 b | $14.2 b | $26.8 b |

## PP&E | $12.9 b | $12.6 b | $12.4 b | $12.4 b |

## Goodwill | $9.8 b | $10.1 b | $9.6 b | $7.7 b |

## Total Assets | $43 b | $41.3 b | $41.2 b | $52.7 b |

## Accounts Payable | $1 b | $1.1 b | $1.1 b | $1.2 b |

## Dividends Payable | $341 m | $362 m | $383 m | $391 m |

## Total Debt | $6.6 b | $7.8 b | $9 b | $22 b |

## Current Liabilities | $9.5 b | $10.5 b | $9.2 b | $6.7 b |

## Debt to Assets Ratio | 0.2 x | 0.2 x | 0.2 x | 0.4 x |

FY, 2013^{} | FY, 2014^{} | FY, 2015^{} | FY, 2016^{} | |
---|---|---|---|---|

## Net Income | $2.6 b | $2.3 b | $4.4 b | $1.4 b |

## Accounts Receivable | $113 m | $195 m | $171 m | $177 m |

## Inventories | ($154 m) | ($297 m) | ($257 m) | ($98 m) |

## Accounts Payable | $256 m | $225 m | $742 m | $652 m |

## Cash From Operating Activities | $3.3 b | $3.7 b | $3 b | $3.2 b |

## Purchases of PP&E | $1.1 b | $1.1 b | $1.1 b | $1.1 b |

## Cash From Investing Activities | $3.9 b | ($202 m) | $406 m | $248 m |

## Short-term Borrowings | $1.3 b | $1.8 b | ||

## Long-term Borrowings | $303 m | $577 m | $2.5 b | $14.9 b |

## Dividends Paid | ($882 m) | ($1.3 b) | ($1.4 b) | ($1.5 b) |

## Cash From Financing Activities | $6.7 b | $2.7 b | $2.2 b | $11.1 b |

## Interest Paid | $148 m | $182 m | $166 m | $181 m |

## Income Taxes Paid | $1 b | $448 m | $631 m | $620 m |

FY, 2014 | FY, 2015 | FY, 2016 | |
---|---|---|---|

## Products | 10 k^{} | 1.5 k^{} | 1.5 k^{} |

## New Product Launches | ^{} | 38^{} | ^{} |

- Source: Company Filings

Acquired Company | Date | Deal Size |
---|---|---|

Alere | April 15, 2017 | $5.3 b |

St. Jude Medical | April 28, 2016 | $25 b |

Kalila Medical | April 06, 2016 | |

Alere | February 02, 2016 | $5.8 b |